NCT01948531 (E2912) is a Phase 4 clinical trial of Gynomunal® gel in Wrinkles, sponsored by Derming SRL.

Who is sponsoring NCT01948531?

NCT01948531 is sponsored by Derming SRL.

What drugs are being tested in NCT01948531?

Interventions in NCT01948531: Gynomunal® gel.

Is NCT01948531 still recruiting?

NCT01948531 is currently completed. Last updated 19 September 2013.

Last reviewed 2013-09-19 · How we verify

NCT01948531: E2912

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical and Instrumental Evaluation of a Topical "Antiage" Formulation for the Face

Completed Phase 4 Last updated 19 September 2013

What this trial tests

Phase 4 trial testing Gynomunal® gel in Wrinkles in 33 participants. Completed in 1 February 2013.

Timeline

1 December 2012

Primary endpoint
1 January 2013

1 February 2013

Quick facts

Lead sponsor	Derming SRL
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	33
Start date	1 December 2012
Primary completion	1 January 2013
Estimated completion	1 February 2013
Sites	1 location across Italy

Drugs / interventions tested

Gynomunal® gel — full drug profile →

Conditions studied

Wrinkles — all drugs for Wrinkles →

Sponsor

Derming SRL — full company profile →

Who can join

Adults 35 to 65, female only, with Wrinkles. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Wrinkles profilometry (Ra - micrometers)
Time frame: 4 weeks
A picture of crow's feet area is taken thanks to Primos compact portable device (GFMesstechnik); Primos software is able to elaborate 3D representations of skin wrinkles as well as to measure skin principal profilometric parameters in vivo or on skin replicas. As a measuring method Primos compact uses a digital stripe projection based on micro mirrors which allows for fast and highly precise meas

Sponsor's own description

Aim of the study is to evaluate clinically and by non-invasive instrumental evaluations the "antiage" activity of Gynomunal® gel after one single application on the face (short term evaluation) and 4 weeks of repeated use twice daily (long term evaluation) by healthy female volunteers. It is also aim of this study to evaluate cosmetic acceptability by the volunteers and efficacy and tolerance both by investigator and volunteers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Wrinkles

Currently open trials in the same condition.

NCT07495865 — Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2 · recruiting
NCT07111156 — A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wr · NA · active not recruiting
NCT06724510 — Safety and Efficacy Evaluation of High Intensity Focused Ultrasound Device in Eyebrow Lifting · NA · recruiting

Other Derming SRL trials

Trials by the same sponsor.

NCT04239768 — Efficacy of an Antiage Aesthetic Treatment for the Middle and Inferior Third of the Face · NA · completed
NCT04113265 — Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms · NA · completed
NCT04002856 — Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck · NA · completed
NCT03881189 — Efficacy and Tolerance Evaluation of an Injective Treatment for the Area Around the Eyes · NA · completed
NCT03801343 — Efficacy and Tolerance Evaluation of an Amino Acid Food Supplement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01948531 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Derming SRL
Last refreshed: 19 September 2013

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01948531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing